BIG PHARMA EARNINGS WATCH: AMGEN, ABBVIE & BRISTOL-MYERS SQUIBB

Brand Name Drug Companies Complete Sweep of Big Pharma Giants Who Beat Wall Street Expectations After Price Hikes In January

In a final round of first quarter earnings reports, three more Big Pharma giants announced they surpassed earnings expectations after hiking prices on American patients. Amgen, AbbVie and Bristol-Myers Squibb all reported sky-high profits after hiking prices on American patients earlier this year.

Last week, brand name drug company Amgen announced it had topped Wall Street expectations on its earnings in the first quarter.

On Friday, Big Pharma giant AbbVie reported sky-high profits – beating Wall Street expectations.
On Thursday, Bristol-Myers Squibb announced stronger-than-expected first-quarter earnings.

All three companies’ expectation-besting earnings come after they participated in a series of price hikes in the past year, despite the mounting crisis of affordability across the country.

Amgen

AbbVie

Amgen, AbbVie and Bristol-Myers Squibb join a slew of Big Pharma giants who have reported expectation-besting earnings for the first quarter of 2020 after hiking prices on American patients – AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Eli Lilly, Roche and Johnson & Johnson.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.